Form DRS - Draft Registration Statement:
SEC Accession No. 0001641172-25-008301
Filing Date
2025-05-02
Accepted
2025-05-02 14:45:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 551662
2 GRAPHIC drs_001.jpg GRAPHIC 26461
3 GRAPHIC drs_002.jpg GRAPHIC 39091
4 GRAPHIC drs_003.jpg GRAPHIC 40549
5 GRAPHIC drs_004.jpg GRAPHIC 39437
  Complete submission text file 0001641172-25-008301.txt   753756
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07971 | Film No.: 25907702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)